DrugShortagePulse: Endocrinology/Metabolism
33 drugShortagePulse: Endocrinology/Metabolism are listed from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-05-14 to 2026-10-27; the most frequent is Fresenius Kabi USA, LLC with 4. Data last updated 2026-11-04; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list)
Includes: Manufacturer, Drug, Stage, Availability, Updated, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
33 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), dated 2026-05-14 to 2026-10-27. Most frequent: Fresenius Kabi USA, LLC (4). Each record links to a full report and the official source.
Last updated 2026-11-04. Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).
Get new DrugShortagePulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- Fresenius Kabi USA, LLC (4)
- Hospira, Inc., a Pfizer Company (3)
- Baxter Healthcare (3)
- Eli Lilly and Co. (3)
- Novo Nordisk, Inc. (3)
How do I get new drugShortagePulse: Endocrinology/Metabolism by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top drugShortagePulse: Endocrinology/Metabolism right now?
| Record | Drug | Stage | Availability |
|---|---|---|---|
| Hospira, Inc., a Pfizer Company | Dextrose Monohydrate 50% Injection | Shortage revised (availability or dates changed) | Unavailable |
| Fresenius Kabi USA, LLC | Sodium Acetate Injection | Shortage revised (availability or dates changed) | Unavailable |
| Baxter Healthcare | Dextrose Monohydrate 5% Injection | New shortage posted | Available |
| Hospira, Inc., a Pfizer Company | Sodium Bicarbonate Injection | Shortage revised (availability or dates changed) | Limited availability |
| Eli Lilly and Co. | Insulin Lispro Injection | Manufacturer discontinuation | |
| Eli Lilly and Co. | Insulin Lispro Protamine and Insulin Lispro Injection | Manufacturer discontinuation | |
| Eli Lilly and Co. | Insulin Glargine-aglr Injection | Manufacturer discontinuation | |
| Novo Nordisk, Inc. | Liraglutide Injection | Manufacturer discontinuation | |
| Teva Pharmaceuticals USA, Inc. | Liraglutide Injection | Manufacturer discontinuation | |
| Otsuka ICU Medical LLC | Dextrose Monohydrate 10% Injection | Shortage reverified (still listed) | Unavailable |
| Mylan Pharmaceuticals Inc., a Viatris Company | Metformin Hydrochloride Tablet, Extended Release | Manufacturer discontinuation | |
| Hospira, Inc., a Pfizer Company | Sodium Acetate Injection | Shortage revised (availability or dates changed) | Available |
| Baxter Healthcare | Dextrose Monohydrate 70% Injection | Shortage revised (availability or dates changed) | Available |
| Meitheal Pharmaceuticals, Inc. | Liraglutide Injection | Shortage revised (availability or dates changed) | Available |
| Sanofi-Aventis U.S. LLC | Glyburide Tablet | Manufacturer discontinuation | |
| Novo Nordisk, Inc. | 🔒 Unlock all 33 records → | ||
| Amphastar Pharmaceuticals, Inc. | 🔒 Unlock all 33 records → | ||
| Amphastar Pharmaceuticals, Inc. | 🔒 Unlock all 33 records → | ||
Browse 18 more matching record reports
- Novo Nordisk, Inc.
- Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals, Inc.
- Novo Nordisk, Inc.
- Somerset Therapeutics, LLC
- B. Braun Medical Inc.
- B. Braun Medical Inc.
- B. Braun Medical Inc.
- Otsuka ICU Medical LLC
- Baxter Healthcare
- Long Grove Pharmaceuticals LLC
- Otsuka ICU Medical LLC
- Fresenius Kabi USA, LLC
- Fresenius Kabi USA, LLC
- Fresenius Kabi USA, LLC
- Exela Pharma Sciences, LLC
- Hikma Pharmaceuticals USA, Inc.
- Hikma Pharmaceuticals USA, Inc.
Browse all DrugShortagePulse record reports
Which related categories and locations should I check?
Browse by stage
Shortage reverified (still listed) (173) Shortage revised (availability or dates changed) (84) Manufacturer discontinuation (78) Resolved (10) New shortage posted (8)
Browse by therapeutic category
Anesthesia (73) Cardiovascular (35) Analgesia/Addiction (32) Oncology (32) Psychiatry (32) Anti-Infective (30) Neurology (15) Other (12) Rheumatology (10) Gastroenterology (9) Hematology (9) Dermatology (8) Antiviral (7) Pulmonary/Allergy (5) Medical Imaging (4)
Frequently asked questions
How many drugShortagePulse: Endocrinology/Metabolism are listed?
33 records from openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list), last refreshed automatically. The most recent is dated 2026-10-27.
Can I get alerts for Endocrinology/Metabolism?
Yes. DrugShortagePulse can email you new records matching this filter; plans are listed on the DrugShortagePulse page.
Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list). Informational only. RSS feed of new records